| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $531.8M | +24.1% |
| Cost of Revenue | $123.5M | +25.6% |
| Gross Profit | $408.4M | +23.7% |
| R&D Expense | $195.1M | +21.3% |
| SG&A Expense | $81.2M | +16.0% |
| Operating Income | -$91.9M | -0.8% |
| Pre-tax Income | -$66.0M | -0.3% |
| Income Tax | $5.8M | +69.3% |
| Net Income | -$71.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.8M | +52.1% |
| Short-term Investments | $628.6M | +33.1% |
| Accounts Receivable | $119.9M | +32.2% |
| Current Assets | $873.0M | +34.5% |
| Total Assets | $1.34B | +18.7% |
| Current Liabilities | $407.5M | +28.3% |
| Total Liabilities | $453.9M | +27.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $145.7M | +31.4% |
| Capital Expenditures | $3.5M | +10.1% |
| Investing Cash Flow | -$152.3M | +7.9% |
| Financing Cash Flow | $31.2M | +47.0% |
| Free Cash Flow | $142.3M | +32.0% |
| -3.7% |
| EPS (Basic) | -$0.62 | +1.6% |
| EPS (Diluted) | -$0.62 | +1.6% |
| Stockholders' Equity |
| $887.4M |
| +14.7% |